quinacrine has been researched along with gsk 369796 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Balasubramanian, A; Bhattacharjee, AK; Kulkarni, AA; Padmanabhan, R; Teramoto, T | 1 |
1 review(s) available for quinacrine and gsk 369796
| Article | Year |
|---|---|
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
1 other study(ies) available for quinacrine and gsk 369796
| Article | Year |
|---|---|
Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus.
Topics: Amodiaquine; Antimalarials; Antiviral Agents; Autophagy; Computer Simulation; Dengue Virus; Drug Discovery; Humans; Mefloquine; Quinacrine; Replicon; Virus Replication; Zika Virus | 2017 |